Sleep–wake functioning along the cancer continuum: focus group results from the Patient‐Reported Outcomes Measurement Information System (PROMIS®)

Objective: Cancer and its treatments disturb sleep–wake functioning; however, there is little information available on the characteristics and consequences of sleep problems associated with cancer. As part of an effort to improve measurement of sleep–wake functioning, we explored the scope of difficulties with sleep in a diverse group of patients diagnosed with cancer.

[1]  J. Parish.  Sleep-related problems in common medical conditions. , 2009, Chest.

[2]  Sue J. Wilson,et al.  The Experience of Poor Sleep and its Consequences: a Qualitative Study involving People referred for Cognitive-Behavioural Management of Chronic Insomnia , 2008 .

[3]  A. Berger,et al.  Modifying cancer-related fatigue by optimizing sleep quality. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  M. Sateia,et al.  Sleep and cancer: Recent developments , 2008, Current oncology reports.

[5]  C. Morin,et al.  Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Morin,et al.  Insomnia in the context of cancer: a review of a neglected problem. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Greenwald,et al.  Sleep loss and REM sleep loss are hyperalgesic. , 2006, Sleep.

[8]  C. Morin,et al.  Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. , 2001, Sleep.

[9]  S. McMillan,et al.  Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. , 2004, Oncology nursing forum.

[10]  T. Furukawa,et al.  Associated and predictive factors of sleep disturbance in advanced cancer patients , 2007, Psycho-oncology.

[11]  P. Stone,et al.  Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. , 2006, Journal of pain and symptom management.

[12]  A. Krystal.  Treating the health, quality of life, and functional impairments in insomnia. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[13]  M. Perlis,et al.  Cancer-related fatigue and sleep disorders. , 2007, The oncologist.

[14]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[15]  A. Dewey.  Psychosocial interventions for reducing fatigue during cancer treatment in adults. , 2010, International journal of evidence-based healthcare.

[16]  R. Dantzer,et al.  A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms , 2004, Neuroimmunomodulation.

[17]  A. Berger,et al.  Current methodological approaches to the study of sleep disturbances and quality of life in adults with cancer: a systematic review , 2007, Psycho-oncology.

[18]  M. Hertzog,et al.  Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy , 2009, Supportive Care in Cancer.

[19]  C. Rock,et al.  The relative importance of specific risk factors for insomnia in women treated for early‐stage breast cancer , 2008, Psycho-oncology.

[20]  S. Dirksen,et al.  Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. , 2007, Oncology nursing forum.

[21]  M. Hotopf,et al.  A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. , 2008, Journal of the National Cancer Institute.

[22]  Kathryn A. Lee,et al.  Impaired sleep and rhythms in persons with cancer. , 2004, Sleep medicine reviews.

[23]  Z. Hall.  Cancer , 1906, The Hospital.

[24]  A. El‐Solh,et al.  Pharmacotherapy of insomnia , 2008, Expert opinion on pharmacotherapy.

[25]  D. Feldman-Stewart,et al.  How to provide insomnia interventions to people with cancer: insights from patients , 2007, Psycho-oncology.

[26]  Kevin Fiscella,et al.  Mechanisms of cancer-related fatigue. , 2007, The oncologist.

[27]  B. Given,et al.  Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. , 2007, Oncology nursing forum.

[28]  L. Nail,et al.  Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. , 2006, Oncology nursing forum.

[29]  S. Passik,et al.  An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. , 2003, Journal of pain and symptom management.

[30]  Judith R Davidson,et al.  Sleep disturbance in cancer patients. , 2002, Social science & medicine.

[31]  J. Bower,et al.  Cancer-related fatigue: Links with inflammation in cancer patients and survivors , 2007, Brain, Behavior, and Immunity.

[32]  Sonia Ancoli-Israel,et al.  Recommendations for a standard research assessment of insomnia. , 2006, Sleep.

[33]  Frank Baker,et al.  Adult cancer survivors: How are they faring? , 2005, Cancer.

[34]  A. Barsevick,et al.  Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. , 2005, Oncology nursing forum.

[35]  M. Stefanek,et al.  Sleep alterations in cancer patients. , 1999, Cancer nursing.

[36]  S. Beck,et al.  Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. , 2007, Clinical journal of oncology nursing.

[37]  S. Dickerson,et al.  Diurnal cortisol rhythm and fatigue in breast cancer survivors , 2005, Psychoneuroendocrinology.

[38]  C. Morin,et al.  Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: Immunologic effects. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.